Prescription Justice heartily endorses Utah bill HB 163, The Prescription Drug Affordability Act, and applauds Utah Representative Norman Thurston (R-63), its lead sponsor. The bill envisions the federal government permitting Utah to import wholesale quantities of FDA-approved drugs from Canada, which would then be dispensed to patients at retail pharmacies and hospitals in Utah. Canadian wholesale pharmacy prices are much lower on many expensive brand name drugs. Utahans would stand to save hundreds of millions of dollars on their collective pharmacy bill.
The bill’s passage would authorize a study, one lead by the Utah Department of Health on the creation of a wholesale drug importation program, one that would operate in accordance with U.S. law. Specifically, Section 804 of the Food, Drug and Cosmetic Act, called Importation of Prescription Drugs, makes wholesale and personal importation of prescription drugs from Canada lawful – but only if the Secretary of Health and Human Services certifies that the practice poses no additional risk to the public’s health and safety and will result in a significant reduction in the cost of covered products to the American consumer. HB 163 endeavors that Utah’s program will receive such certification. (more…)
As we leave 2017 behind, the crisis of high prescription drug prices continues to threaten the health and well-being of Americans who struggle to access life-saving medications. Millions of Americans are forced to choose between taking the medicine they need, paying the rent or buying food for their families; tens of millions don't take prescribed medication; and federal and state budgets are overwhelmed. At Prescription Justice, we are dedicated solely to putting an end to this devastating crisis.
Over the past year, we have concentrated our efforts and resources on advocating for regulatory and legislative reforms and commonsense policies to lower domestic drug prices and expand access to lower cost medication from pharmacies in other countries. (more…)
President Trump reinvigorated the drug price policy debate by recently stating that prescription drug prices "are out of control" and, for a second time, that drug companies are "getting away with murder". He's expected to soon announce a bi-partisan drug price task force to examine prescription drug costs. The president's renewed focus on lowering drug costs is a relief from the misaligned priority of healthcare reform, which seems to have overshadowed Americans most pressing healthcare concern: soaring drug costs.
In his most recent remarks, President Trump focused on the fact that prescription drugs are much cheaper in other countries. In fact, it's common for brand-name prescription drug prices to be as much as 90 percent lower in pharmacies outside the U.S., which is why millions of Americans, despite federal restrictions, have had to import medication from Canada and elsewhere. Unfortunately, the law and misleading public information campaigns sponsored by drug companies scare Americans away from more affordable medication. (more…)